Perigon Wealth Management, LLC Amgen Inc Transaction History

Perigon Wealth Management, LLC

$3.67 Billion
Q3 2024

A detailed history of Perigon Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Perigon Wealth Management, LLC holds 12,909 shares of AMGN stock, worth $3.39 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

12,909

Previous 12,736 1.36%

Holding current value

$3.39 Million

Previous $3.98 Million 4.52%

% of portfolio

0.11%

Previous 0.12%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$309.38 - $337.38 $53,522 - $58,366	173 Added 1.36%	12,909 $4.16 Million
Q2 2024 Aug 02, 2024	BUY	$262.75 - $319.31 $141,885 - $172,427	540 Added 4.43%	12,736 $3.98 Million
Q1 2024 Apr 29, 2024	BUY	$268.87 - $324.56 $73,939 - $89,254	275 Added 2.31%	12,196 $3.47 Million
Q4 2023 Jan 29, 2024	BUY	$255.7 - $288.46 $6,392 - $7,211	25 Added 0.21%	11,921 $3.43 Million
Q3 2023 Oct 30, 2023	SELL	$218.65 - $271.46 $67,344 - $83,609	-308 Reduced 2.52%	11,896 $3.2 Million
Q2 2023 Aug 02, 2023	BUY	$214.27 - $253.37 $353,545 - $418,060	1,650 Added 15.63%	12,204 $2.71 Million
Q1 2023 May 03, 2023	BUY	$225.79 - $275.2 $81,284 - $99,072	360 Added 3.53%	10,554 $2.55 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $448,669 - $570,088	1,959 Added 23.79%	10,194 $2.68 Million
Q3 2022 Dec 13, 2022	BUY	$224.46 - $253.15 $54,543 - $61,515	243 Added 3.04%	8,235 $1.86 Million
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $81,902 - $91,142	355 Added 4.65%	7,992 $1.95 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $107,223 - $118,616	489 Added 6.84%	7,637 $1.85 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $33,809 - $38,692	-170 Reduced 2.32%	7,148 $1.61 Million
Q3 2021 Nov 01, 2021	BUY	$212.27 - $248.7 $1.55 Million - $1.82 Million	7,318 New	7,318 $1.56 Million
Q3 2021 Oct 25, 2021	SELL	$212.27 - $248.7 $1.75 Million - $2.05 Million	-8,251 Closed	0 $0
Q2 2021 Jul 19, 2021	BUY	$233.58 - $259.14 $7,708 - $8,551	33 Added 0.4%	8,251 $2.01 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $201,938 - $235,326	910 Added 12.45%	8,218 $2.05 Million
Q4 2020 Jan 28, 2021	BUY	$216.38 - $257.67 $897,977 - $1.07 Million	4,150 Added 131.41%	7,308 $1.68 Million
Q3 2020 Nov 03, 2020	BUY	$234.65 - $260.95 $107,000 - $118,993	456 Added 16.88%	3,158 $803,000
Q2 2020 Jul 29, 2020	BUY	$197.81 - $242.74 $95,344 - $117,000	482 Added 21.71%	2,702 $637,000
Q1 2020 Apr 17, 2020	BUY	$182.24 - $241.7 $136,862 - $181,516	751 Added 51.12%	2,220 $484,000
Q4 2019 Jan 13, 2020	BUY	$189.21 - $243.2 $26,300 - $33,804	139 Added 10.45%	1,469 $353,000
Q3 2019 Oct 25, 2019	SELL	$174.11 - $208.62 $131,104 - $157,090	-753 Reduced 36.15%	1,330 $272,000
Q2 2019 Aug 05, 2019	BUY	$166.7 - $195.41 $13,336 - $15,632	80 Added 3.99%	2,083 $384,000
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $3,617 - $4,077	20 Added 1.01%	2,003 $362,000
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $232,990 - $271,974	-1,306 Reduced 39.71%	1,983 $394,000
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $353,348 - $398,353	-1,907 Reduced 36.7%	3,289 $682,000
Q2 2018 Aug 09, 2018	BUY	$166.05 - $186.51 $449,165 - $504,509	2,705 Added 108.59%	5,196 $959,000
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $320,900 - $375,012	1,894 Added 317.25%	2,491 $425,000
Q3 2017 Dec 05, 2017	SELL	$167.29 - $191.0 $4.42 Million - $5.05 Million	-26,430 Reduced 97.79%	597 $111,000
Q2 2017 Sep 12, 2017	BUY	N/A	27,027 New	27,027 $4.66 Million
Q3 2011 Nov 14, 2022	BUY	N/A	243	8,235 $1.86 Million

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

407M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perigon Wealth Management, LLC with notifications on news.

Account

Perigon Wealth Management, LLC Amgen Inc Transaction History